Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mec
 

Bionovo, Inc. (Nasdaq: BNVI) announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth. These results provide evidence that drugs that stimulate the production of or activate ERb are potential new therapies to prevent breast cancer...

More...